Edition:
United States

21st North Inc (ULGX.PK)

ULGX.PK on OTC Markets Group

0.00USD
--
Change (% chg)

-- (--)
Prev Close
$0.00
Open
--
Day's High
--
Day's Low
--
Volume
--
Avg. Vol
75,334
52-wk High
$0.00
52-wk Low
$0.00

ULGX.PK

Chart for ULGX.PK

About

21st North Inc., formerly Urologix Inc., was engaged in developing, manufacturing, marketing and distributing medical products. The Company offered its products for the treatment of obstruction and symptoms due to Benign Prostatic Hyperplasia (BPH). The Company has no operations. The Company intends to dissolve.
No analyst recommendations are available for ULGX.PK.

Overall

Beta: 4.39
Market Cap(Mil.): $0.06
Shares Outstanding(Mil.): 21.82
Dividend: --
Yield (%): --

Financials

  ULGX.PK Industry Sector
P/E (TTM): -- 51.37 30.08
EPS (TTM): -0.22 -- --
ROI: -250.90 6.70 13.25
ROE: -- 10.65 14.41

More From Around the Web

Competitors

Earnings vs. Estimates